CD4+CD25+ T-cell populations expressing CD134 and GITR are associated with disease activity in patients with Wegener's granulomatosis

Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association
B WildeO Witzke

Abstract

An increased CD4(+) CD25(+) T-cell population is observed in Wegener's granulomatosis (WG). This T-cell population is not well characterized yet and their contribution to the disease pathogenesis remains obscure. Thirty patients with WG and 18 healthy controls (HC) were included in this study. The disease activity and extension were measured by the Birmingham Vasculitis Activity Score (BVAS) and the Disease Extent Index (DEI). Lymphocytes from peripheral blood were analysed by FACS for the expression of CD4, CD25, CD134 and GITR. Cytokine expression in these subsets was assessed too. Nasal, lung and renal tissues from WG patients were immunohistochemically stained for CD3 and CD134. The percentage of CD134(+) as well as GITR(+) expressing CD4(+)CD25(+) lymphocytes was increased in patients as compared to HC (37 +/- 12% versus 27 +/- 8%, P = 0.005; 18 +/- 9% versus 11 +/- 6%, P = 0.003). The expression of CD134 and GITR showed a significant correlation with disease activity (r = 0.5, P = 0.009; r = 0.55, P = 0.001). Most of these displayed the phenotype of effector memory T-cells (94 +/- 4% and 91 +/- 6%). CD134 T-cells were found in tissues affected by WG. CD4(+)CD25(+) effector memory T-cells expressing CD134 and GITR seem to ...Continue Reading

References

Nov 1, 1989·Archives of Internal Medicine·J W TervaertT H The
Mar 1, 1993·Clinical and Experimental Immunology·C A StegemanC G Kallenberg
May 18, 1999·The Journal of Allergy and Clinical Immunology·E R PopaJ W Tervaert
Aug 22, 2000·The Journal of Pathology·A MüllerW L Gross
Jul 24, 2001·The Journal of Immunology : Official Journal of the American Association of Immunologists·C Baecher-AllanD A Hafler
Aug 2, 2001·Nature Medicine·P Bansal-PakalaM Croft
Oct 27, 2001·Clinical and Experimental Immunology·K SteinerB M Bröker
Mar 27, 2003·Nature Reviews. Immunology·Jeffrey A Bluestone, Abul K Abbas
Mar 23, 2004·Annual Review of Immunology·Federica SallustoAntonio Lanzavecchia
Mar 24, 2004·Seminars in Immunology·Clare Baecher-AllanDavid A Hafler
May 22, 2004·The Journal of Immunology : Official Journal of the American Association of Immunologists·Stephanie K LathropDavid C Parker
Mar 15, 2005·Clinical and Experimental Immunology·S MarinakiF J Van Der Woude
Mar 17, 2005·European Journal of Immunology·Giuseppe Nocentini, Carlo Riccardi
Mar 18, 2005·Annual Review of Immunology·Tania H Watts
Jul 6, 2005·Clinical and Experimental Immunology·P Lamprecht
Dec 14, 2005·Current Opinion in Rheumatology·Bernhard HellmichWolfgang L Gross
Jan 21, 2006·The Journal of Immunology : Official Journal of the American Association of Immunologists·Minh Diem VuXian Chang Li
Mar 17, 2006·European Journal of Immunology·Cortny A HuddlestonDavid C Parker
Mar 29, 2006·Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association·Smaragdi MarinakiBenito A Yard
May 20, 2006·The Journal of Immunology : Official Journal of the American Association of Immunologists·Teresa Ramirez-MontagutMarcel R M van den Brink
Jul 5, 2006·The Journal of Experimental Medicine·Weihong LiuJeffrey A Bluestone
Jul 14, 2006·Kidney International·W H AbdulahadC G M Kallenberg
Jul 27, 2006·Nature Reviews. Immunology·Ethan M Shevach, Geoffrey L Stephens
Dec 5, 2006·Current Opinion in Rheumatology·Cees Gm Kallenberg
Apr 5, 2007·European Journal of Immunology·Giuseppe NocentiniCarlo Riccardi
May 26, 2007·TheScientificWorldJournal·Ludovic Tibor KrauszCarlo Riccardi
May 29, 2007·Arthritis and Rheumatism·Wayel H AbdulahadCees G M Kallenberg
Jun 19, 2007·Blood·Minh Diem VuXian Chang Li
Jul 21, 2007·The Journal of Immunology : Official Journal of the American Association of Immunologists·Takanori So, Michael Croft

❮ Previous
Next ❯

Citations

Jan 16, 2009·Nephrology·Wayel H AbdulahadCees G M Kallenberg
May 15, 2013·Annals of the Rheumatic Diseases·B WildeJ W Cohen Tervaert
Mar 20, 2010·Arthritis Research & Therapy·Benjamin WildeJan Willem Cohen Tervaert
Sep 6, 2011·Arthritis Research & Therapy·Wayel H AbdulahadCees G M Kallenberg
Dec 15, 2010·Kidney International·Benjamin WildeJan Willem Cohen Tervaert
Jul 29, 2015·Clinical Reviews in Allergy & Immunology·Gwilym J WebbPeter J L Lane
Oct 30, 2014·Frontiers in Immunology·Lucas L LintermansWayel H Abdulahad
Mar 10, 2017·Nature Reviews. Rheumatology·Michael Croft, Richard M Siegel
Oct 12, 2013·Arthritis and Rheumatism·Meghan E Free, Maureen A Su
Mar 6, 2018·Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association·Gerjan J DekkemaJan-Stephan F Sanders
Jun 26, 2018·Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association·Dragana OdobasicStephen R Holdsworth
Aug 1, 2013·Expert Review of Clinical Immunology·Elena Csernok, Wolfgang L Gross
May 30, 2009·Arthritis and Rheumatism·Annelies E BerdenIngeborg M Bajema
May 6, 2017·Clinical Reviews in Allergy & Immunology·Guillermo Carvajal AlegriaDivi Y K Cornec
Dec 15, 2010·Pediatric Allergy and Immunology : Official Publication of the European Society of Pediatric Allergy and Immunology·Wang QinZhang Xueguang
Jul 3, 2021·International Journal of Molecular Sciences·Antje MüllerPeter Lamprecht
Nov 26, 2009·Current Opinion in Rheumatology

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.